The Relative Strength (RS) Rating for Schrodinger entered a new percentile Tuesday, with an increase from 80 to 83.
This exclusive rating from Investor's Business Daily measures share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
History reveals that the best-performing stocks often have an RS Rating north of 80 as they begin their biggest price moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Schrodinger is not currently showing a potential entry point. See if the stock goes on to form a base that could launch a new move.
Schrodinger reported 0% EPS growth in its most recent report, while sales growth came in at 19%.
The company earns the No. 13 rank among its peers in the Medical-Research Equipment/Services industry group. Champions Oncology, Veracyte and Natera are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
